Citation: Duband S, Product Review SafenSound & Safelia
During these check-ups, your healthcare provider will assess your response to the medication, monitor your blood sugar levels, and make any necessary dosage adjustments
All three operate on a cash-pay basis
I think the most mysterious thing about these drugs is their effect on the brain
Long-term safety data is still being collected, but current research suggests no unexpected long-term risks beyond those seen with GLP-1 and GIP medications
The results showed that in high risk patients with T2D liraglutide reduced the risk of MACE by 13% (primary endpoint included cardiovascular death, non-fatal myocardial infarction (MI), and non-fatal stroke) ( In the ELIXA and the EXSCEL trials, GLP-1RAs (once daily lixisenatide and once weekly exenatide, respectively) didnt provide benefit in MACE reduction compared to placebo, but were non-inferior to placebo for the primary composite outcome of MACE